286 related articles for article (PubMed ID: 30376895)
1. Multiple myeloma presenting as cutaneous leukocytoclastic vasculitis and eosinophilia disclosing a T helper type 1/T helper type 2 imbalance: a case report.
Oka S; Ono K; Nohgawa M
J Med Case Rep; 2018 Oct; 12(1):320. PubMed ID: 30376895
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic cutaneous leukocytoclastic vasculitis disclosing multiple myeloma: a case report.
Peterlin P; Ponge T; Blin N; Moreau P; Hamidou M; Agard C
Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):373-4. PubMed ID: 21729687
[TBL] [Abstract][Full Text] [Related]
3. Multiple myeloma with paraneoplastic leucocytoclastic vasculitis.
Jain P; Kumar P; Parikh PM
Indian J Cancer; 2009; 46(2):173-4. PubMed ID: 19346655
[No Abstract] [Full Text] [Related]
4. [Paraneoplastic cutaneous leukocytoclastic vasculitis disclosing IgA multiple myeloma].
Abouzaid C; Zahlane M; Benjilali L; Belaabidia B; Essaadouni L
Presse Med; 2013 Apr; 42(4 Pt 1):482-4. PubMed ID: 22840993
[No Abstract] [Full Text] [Related]
5. Th1/Th2 cells in patients with multiple myeloma.
Murakami H; Ogawara H; Hiroshi H
Hematology; 2004 Feb; 9(1):41-5. PubMed ID: 14965867
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation in T helper 1/T helper 2 cytokine ratios in patients with multiple myeloma.
Sharma A; Khan R; Joshi S; Kumar L; Sharma M
Leuk Lymphoma; 2010 May; 51(5):920-7. PubMed ID: 20367137
[TBL] [Abstract][Full Text] [Related]
7. Henoch-Schönlein purpura: clinicopathologic correlation of cutaneous vascular IgA deposits and the relationship to leukocytoclastic vasculitis.
Helander SD; De Castro FR; Gibson LE
Acta Derm Venereol; 1995 Mar; 75(2):125-9. PubMed ID: 7604640
[TBL] [Abstract][Full Text] [Related]
8. High Th1/Th2 ratio in patients with multiple myeloma.
Ogawara H; Handa H; Yamazaki T; Toda T; Yoshida K; Nishimoto N; Al-ma'Quol WH; Kaneko Y; Matsushima T; Tsukamoto N; Nojima Y; Matsumoto M; Sawamura M; Murakami H
Leuk Res; 2005 Feb; 29(2):135-40. PubMed ID: 15607360
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report.
Noto R; Kamiura N; Ono Y; Tabata S; Hara S; Yokoi H; Yoshimoto A; Yanagita M
BMC Nephrol; 2017 Apr; 18(1):127. PubMed ID: 28385149
[TBL] [Abstract][Full Text] [Related]
10. Leukocytoclastic vasculitis associated with immunoglobulin A lambda monoclonal gammopathy of undetermined significance: A case report and review of previously reported cases.
Umemura H; Yamasaki O; Iwatsuki K
J Dermatol; 2018 Aug; 45(8):1009-1012. PubMed ID: 29766549
[TBL] [Abstract][Full Text] [Related]
11. A novel combination of bortezomib, lenalidomide, and clarithromycin produced stringent complete response in refractory multiple myeloma complicated with diabetes mellitus - clinical significance and possible mechanisms: a case report.
Takemori N; Imai G; Hoshino K; Ooi A; Kojima M
J Med Case Rep; 2018 Feb; 12(1):40. PubMed ID: 29454372
[TBL] [Abstract][Full Text] [Related]
12. Remission of light chain proximal tubulopathy in IgG λ-type multiple myeloma by lenalidomide and dexamethasone therapy.
Kawamoto S; Hidaka Y; Kaneko Y; Misawa H; Nagahori K; Yoshino A; Okamura T; Ban S; Ueda Y; Takeda T
CEN Case Rep; 2019 Aug; 8(3):159-165. PubMed ID: 30721454
[TBL] [Abstract][Full Text] [Related]
13. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
14. Henoch-Schönlein purpura presenting with anuria in an adult.
Weiser JA; Rogers HD; Stokes MB; Grossman ME
Cutis; 2010 Oct; 86(4):181-4. PubMed ID: 21140925
[TBL] [Abstract][Full Text] [Related]
15. Leukocytoclastic (small vessel) vasculitis in multiple myeloma.
Bayer-Garner IB; Smoller BR
Clin Exp Dermatol; 2003 Sep; 28(5):521-4. PubMed ID: 12950344
[TBL] [Abstract][Full Text] [Related]
16. Angiomatoid lesions (leukocytoclastic vasculitis) as paraneoplastic manifestations of multiple myeloma IgA λ.
Carlesimo M; Narcisi A; Orsini D; Di Russo PP; Cortesi G; La Verde G; Giubettini M; Pulcini F; Camplone G
Eur J Dermatol; 2011; 21(2):260-1. PubMed ID: 21382776
[No Abstract] [Full Text] [Related]
17. Small vessel vasculitis of the skin.
Micheletti RG; Werth VP
Rheum Dis Clin North Am; 2015; 41(1):21-32, vii. PubMed ID: 25399937
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous leucoclastic vasculitis (LV) following bortezomib therapy in a myeloma patient; association with pro-inflammatory cytokines.
Min CK; Lee S; Kim YJ; Eom KS; Lee JW; Min WS; Kim CC; Cho CS; Park G
Eur J Haematol; 2006 Mar; 76(3):265-8. PubMed ID: 16451401
[TBL] [Abstract][Full Text] [Related]
19. Ovarian cancer presenting as leukocytoclastic vasculitis.
Stashower ME; Rennie TA; Turiansky GW; Gilliland WR
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 2):287-9. PubMed ID: 10025849
[TBL] [Abstract][Full Text] [Related]
20. Leukocytoclastic vasculitis due to thalidomide in multiple myeloma.
Yildirim ND; Ayer M; Küçükkaya RD; Alpay N; Mete O; Yenerel MN; Yavuz AS; Nalçaci M
Jpn J Clin Oncol; 2007 Sep; 37(9):704-7. PubMed ID: 17709605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
